Burzynski Research Institute, Inc.
Burzynski Research Institute, Inc. (BZYR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BZYR · as of Jun 9, 2026
Key Statistics
Explore Burzynski Research Institute, Inc. Data
bzyr stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bzyr competitorsBZYR
BETRF
BIXT
BVAXF
CPMV
FAMDFStock Performance
Full HistoryAbout Burzynski Research Institute, Inc.
Burzynski Research Institute, Inc. The Burzynski Research Institute, Inc. primarily focuses on the exploration and development of antineoplaston medications designed for cancer treatment. Beyond its research efforts, the company is act…
what is burzynski research institute, inc. · bzyr stock overview · burzynski research institute, inc. company profile · who is burzynski research institute, inc. ceo · bzyr OTC · burzynski research institute, inc. headquarters · burzynski research institute, inc. business segments
About Stock Overview & Key Data
Burzynski Research Institute, Inc. (BZYR) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 2, 1997. As of the latest trading session, BZYR stock price is $0.01, with a market capitalization of $1.4M. The stock has returned -66.45% over the past 12 months and -45.25% year-to-date.
In fiscal year 2025, Burzynski Research Institute, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Burzynski Research Institute, Inc. (BZYR) stock price is $0.01. The stock is traded on OTC under the ticker symbol BZYR. The 52-week range is $0.01 – $0.06.